A 31-year-old man with a double-outlet right ventricle, subaortic ventricular septal defect (VSD), established secondary pulmonary hypertension and Eisenmenger syndrome, sustained significant right torso injuries in a high-velocity road traffic accident. He had been lost to cardiology follow-up for three years prior to the accident, during which time he had good day-to-day functionality ( Table 1) .
A 31-year-old man with a double-outlet right ventricle, subaortic ventricular septal defect (VSD), established secondary pulmonary hypertension and Eisenmenger syndrome, sustained significant right torso injuries in a high-velocity road traffic accident. He had been lost to cardiology follow-up for three years prior to the accident, during which time he had good day-to-day functionality ( Table 1) .
On arrival to hospital, he was neurologically intact with stage 3 finger clubbing, central cyanosis and a loud pansystolic murmur. He was hypotensive, non-invasive blood pressure (NIBP) 65/45 mm Hg, and anaemic, Hb 12.9 g/dL (baseline 22 g/dL). Echocardiography confirmed a 1.6 cm sub-aortic VSD with double-outlet RV (Figure 1) , preserved left and right ventricular systolic function, RV dilatation and an estimated right ventricular systolic pressure of 96 mm Hg.
Axial imaging (Figure 2 ) demonstrated multiple rib fractures, pulmonary contusions, and liver laceration with haemoperitoneum. SpO 2 was 65% on 15 L oxygen via mask/reservoir bag, PaO 2 was 4.2 kPa, which improved to premorbid levels of 75% with 10 cm H 2 O continuous positive airway pressure (CPAP), FiO 2 1.O.
Haemodynamic management consisted of systemic blood pressure augmentation with noradrenaline and vasopressin to limit exacerbation of his right-to-left shunt, with early continuous venovenous haemofiltration to facilitate a conservative fluid management strategy. The liver laceration and pulmonary contusions were managed conservatively. Pulmonary vasodilators, oral sildenafil and intravenous prostacyclin (PGI 2 ) were administered. Early non-invasive ventilation was well tolerated.
On day 7, the patient' s respiratory status deteriorated due to superimposed lung injury and the SpO 2 fell to 30-40% with hypercapnia and hyperlactataemia. The patient was intubated and ventilated with little improvement in oxygenation and hypercapnia. Pumpless AV-ECCO 2 R was instituted (left femoral artery to right femoral vein, no systemic anticoagulation) with the rationale that this would reduce the right-to-left shunt by effectively controlling CO 2 levels and increasing mixed venous oxygen content. Improvements in oxygenation beyond a level that can be expected in patients without Eisenmenger syndrome Novel uses of arteriovenous extracorporeal membrane carbon dioxide removal (AV-ECCO 2 R) -two case studies TE Hughes, A Slack, W Bernal, JA Wendon, SJ Finney, C Willars, G Auzinger Extracorporeal carbon dioxide removal (ECCO 2 R) device technologies have enhanced the management of acute respiratory distress syndrome (ARDS) and other lung pathologies necessitating low tidal volume protective ventilation. We report the novel use of the interventional Lung Assist Membrane Ventilator ® (iLA, Novalung GmbH) in a multi-trauma patient with pulmonary contusion and pre-existing cyanotic congenital heart disease and in a patient with raised intracranial pressure in the context of acute liver failure and primary graft non-function. In both cases, heart-lung interactions were complex, but AV-ECCO 2 R brought about significant improvements in respiratory indices and left/right ventricular function. The device facilitated restoration of homeostasis where other therapeutic options were limited or had failed. were anticipated in view of the very low arterial oxygen saturation. SpO 2 increased from 35% to 65% with 7 L/min sweep gas flow, the pCO 2 fell from 9.5 to 5.4 kPa and serum lactate fell from a peak of 11 mmol/L to 2.3 mmol/L (Figure 3 ). In theory creating an 'A-V fistula' with the AV-ECCO 2 R device could have decreased systemic vascular resistance and increased right to left shunting. This was not of clinical significance in this case. It was anticipated that the reduction in afterload due to the AV shunt would be partly outweighed by the reduction in pulmonary vascular resistance secondary to attenuation of hypoxic pulmonary vasoconstriction.
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Veno-venous extracorporeal membrane oxygenation (VV-ECMO) was relatively contraindicated in view of the need for systemic anticoagulation in a polytrauma patient.
He was subsequently transferred to his congenital heart failure centre with the AV-ECCO 2 R device in situ. Ongoing management included inhaled nitric oxide (NO) and sildenafil. By day 20 following intubation, both NO and the sweep gas flow through the AV-ECCO 2 R membrane had been weaned off; he was extubated the following day and was eventually discharged from hospital.
Case 2: ARDS, right ventricular pressure overload and functional left ventricular outflow tract obstruction following primary graft nonfunction of the liver
A 33-year-old male presented with a diagnosis of acute liver failure following paracetamol and non-steroidal antiinflammatory drug ingestion. At the time of admission to the liver intensive care unit, he was in established multi-organ failure requiring respiratory, cardiovascular and renal support. Prophylactic broad-spectrum antibiotic and antifungal therapy was commenced. A transthoracic echocardiogram demonstrated hyperdynamic biventricular function.
An intracranial pressure (ICP) monitor was inserted and continuous jugular bulb oximetry monitoring was commenced. The ICP was initially elevated at 22 mm Hg but subsequently fell to 12-14 mm Hg.
The INR further increased to >15 and the patient was 'super-urgently' listed for liver transplantation. At the time of transplant listing, serum lactate level had fallen to 2.1 mmol/L, ICP was <15 mm Hg and his cardiorespiratory status had improved (PaO 2 /FiO 2 >26.7 kPa, low dose noradrenaline dose 0.05 µg/kg/min).
A compatible donor liver became available within four days of admission. The peri-operative course was complicated by 
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primary non-function (PNF) and a subcapsular haematoma of the graft requiring intraoperative packing. On return to the intensive care unit, the patient was haemodynamically unstable ( Table 2) . Functional markers of fluid responsiveness suggested a preload-dependent state accompanied by severe capillary leak with a high extravascular lung water index (EVLWI) of 20 mL/kg (normal range 3-7 mL/kg). Further fluid administration led to worsening hypoxaemia (PaO 2 /FiO 2 of 9.2 kPa) on pressure-limited ventilation with FiO 2 of 1.0 and PEEP 12 cm H 2 O.
The patient was hypercapnic (PaCO 2 8.8 kPa), which led to a rise in ICP to 25 mm Hg. Despite severe acute respiratory distress syndrome (ARDS), limitation of tidal volume was not feasible given the high CO 2 and elevated ICP. Attempts to increase the respiratory rate to reduce CO 2 were limited by worsening of auto-PEEP. There was profound acidaemia and hyperlactataemia (12 mmol/L) despite ultra-high volume haemofiltration (90 mL/kg/hr).
Bedside transoesophageal echo (TOE) demonstrated hyperdynamic left ventricle, evidence of reduced left ventricular volume, a significant gradient across the left ventricular outflow tract (LVOT) and systolic anterior motion (SAM) of the anterior mitral valve leaflet (Figure 4) . The right ventricle was mildly dilated and the systolic pulmonary arterial pressure was elevated at 60 mm Hg. Echocardiographic features were typical of functional LVOT obstruction induced by hypovolaemia, ventricular interdependence and high dose inotropic support. Sildenafil and nebulised PGI 2 were administered and cautious intravascular volume therapy attempted, despite critical hypoxaemia, to reduce inotropic requirements and to relieve the dynamic LVOT obstruction.
Other attempts at rescue therapy for ARDS in the context of the right-sided pressure overload, such as prone ventilation, were thought to be impractical given the intracranial hypertension (ICH) and open abdomen.
AV-ECCO 2 R was commenced. The PaCO 2 dropped from 7.9 kPa prior to treatment to 4.4 kPa within eight hours. This enabled limitation of tidal volumes. The PaO 2 /FiO 2 ratio improved to 18.4 kPa, EVLWI decreased to 12 mL/kg and the right atrial pressure dropped to 13-14 mm Hg with reduction in the pulmonary artery systolic pressure to approximately 35 mm Hg. VV-ECMO was contraindicated in view of the need for systemic anticoagulation in a patient with ICP monitoring, PNF of the graft and packing of the liver due to uncontrollable bleeding from the liver capsule.
The cardiac index improved to more than 5 L/min/m 2 , noradrenaline requirements halved and the metabolic status improved with arterial lactate level falling to 3 mmol/L. The ICP normalised. Repeat TOE showed resolution of dynamic left ventricular outflow tract obstruction, normalisation of right-sided pressures and normal biventricular function. The patient improved to an extent whereby urgent re-do orthotopic liver transplant was possible. A compatible donor liver became available after five days on AV-ECCO 2 R support. He was successfully re-transplanted and AV-ECCO 2 R was stopped on postoperative day one. Complications included pulmonary haemorrhage from a pulmonary artery pseudoaneurysm requiring embolisation and systemic aspergillosis, which eventually responded to dual antifungal therapy. He was eventually transferred back to his local hospital, following a prolonged and complicated ICU stay, but unfortunately died three months later.
Discussion
The two cases reported here show unique and novel indications for pumpless extracorporeal carbon dioxide removal. Given the underlying disease processes, with a high risk of systemic and intracranial haemorrhage, pump-driven ECMO support with anticoagulation was relatively contraindicated. This is not an absolute contraindication and VV-ECMO has been used successfully in patients with severe polytrauma, but with a higher bleeding risk. 1 In the first case, the underlying pathophysiology for cardiorespiratory failure was largely driven by hypercapnia, acidosis and subsequent onset or worsening of pulmonary hypertension and right heart dysfunction and an increase in right to left shunt. In the second case, despite preserved left ventricular function, ventricular interdependence caused functional impairment of filling and outflow of the LV.
The first patient demonstrated significant hypoxaemia at baseline due to Eisenmenger syndrome. He had been lost to follow-up, therefore medical management in the form of long-term combination therapy for the reduction of pulmonary arterial hypertension had not been optimised. The principal management goal in critically ill patients with Eisenmenger syndrome is avoidance of acute increases in pulmonary vascular resistance (PVR) and decreases in systemic vascular resistance (SVR) and support of right ventricular function.
This patient had an intra-cardiac shunt with severe, untreated and potentially irreversible pulmonary hypertension and an acute intrapulmonary shunt from the traumatic lung contusion and secondary lung injury. The sudden deterioration in gas exchange coupled with hyperlactataemia probably represented a vicious circle of alveolar hypoxia/hypercapnia, increasing PVR and worsening of shunt, culminating in acute right ventricular dilatation with diminished left ventricular systolic function and filling leading to low cardiac output state. We considered that the rise in PVR secondary to pulmonary contusion and functional shunt might be amenable to therapy. We proceeded on the basis that if this could be attenuated, the acute right heart failure might be reversed.
Failure to achieve acceptable gas exchange with simple mechanical ventilation manoeuvres necessitated the use of the AV-ECCO 2 R. The potential for dramatic improvements in gas exchange along with the requirement for little or no anticoagulation, given the lung and liver injuries, made AV-ECCO 2 R an attractive therapeutic option. The average oxygen transfer capacity of approximately 42 mL/min is normally limited by the fact that arterial blood entering the membrane lung is relatively well oxygenated. 2 The rise in PO 2 which occurs may also be due to a decrement in alveolar CO 2 , according to the alveolar gas equation this must be accompanied by a concomitant increase in the partial pressure of other respiratory gases (mainly alveolar PO 2 ). It is important to remember, though, that an increase in PO 2 will not necessarily equate to enhanced oxygen delivery (DO 2 ), as part of the cardiac output will be diverted through the device. 3 Overall DO 2 may therefore be reduced despite improved oxygenation.
In patients with ARDS, ECCO 2 R may attenuate hypoxic pulmonary vasoconstriction (HPV) and consequently increase V/Q mismatch leading to desaturation. We hypothesised that in our patient diminishing the HPV might be desirable if it helped to normalise the SVR:PVR ratio and decrease the shunt fraction.
Eisenmenger syndrome is diagnosed when pulmonary artery pressures exceed systemic pressures and lead to shunt reversal under long standing left-to-right shunt conditions. 4 The increased pulmonary pressures are believed to result from endothelial dysfunction, abnormal shear stress, circumferential wall stretch and imbalance of vasoactive mediators that occurs with increased pulmonary flow and pressure.
The initial functional and reversible vasoconstriction of pulmonary vasculature later becomes fixed. 4 Right ventricular function is often relatively preserved with chronic adaptation to high pressures from birth. 5 Survival in patients with Eisenmenger syndrome is lower than in the general population with only 55% reaching 50 years of age; death is often precipitated by respiratory infections, trauma and pulmonary embolic disease. 6 ECCO 2 R provides a physiologically plausible therapeutic option under such circumstances, despite the risk of paradoxical emboli and stroke.
The second case highlights a unique series of problems that can complicate primary graft non-function in patients transplanted for acute liver failure. While 'protective' ventilatory strategies are a standard of care in patients with or at risk of lung injury, some patients are unable to tolerate rising CO 2 levels or high respiratory rates during low tidal volume ventilation. Permissive hypercapnia may be entirely acceptable in a wide variety of scenarios, but there are some instances, such as intracranial or pulmonary hypertension, where it is best avoided.
The use of AV-ECCO 2 R has been previously described in the neurosurgical setting for the prevention of secondary brain injury. 7 Facilitation of CO 2 removal diminishes cerebral blood flow and therefore intracranial pressure.
Hypovolaemia could not be aggressively corrected because of worsening respiratory indices with fluid loading, and for fear of exacerbating pulmonary hypertension and right ventricular pressure overload, leaving the patient heavily pressor-and inotrope-dependent with dynamic LVOT obstruction.
Systolic anterior motion (SAM) of the anterior mitral valve leaflet with functional LVOT obstruction is an increasingly recognised complication in ICU patients, outside the classical presentation in the context of hypertrophic cardiomyopathy. 8 It has been reported in patients with apical ballooning syndrome and during hypovolaemia and high-dose inotropic support, predominantly in patients with pre-existing arterial hypertension. RV pressure overload due to septal shift and ventricular interdependence can lead to functional hypovolaemia/tamponade of the LV; the concomitant hypotension is frequently treated with escalating doses of inotropes/vasopressors which in turn leads to a viscious cycle of worsening LVOT obstruction.
The deterioration in respiratory indices could not be effectively corrected because the presence of a persistently elevated ICP precluded the institution of higher levels of PEEP or high frequency oscillatory ventilation. Proning was not practical in the context of an open abdomen and ICH. 'Protective' ventilatory strategies advocated by ARDSnet could not be employed as reduction in minute ventilation exacerbated hypercapnia and the elevation in intracranial pressure.
AV-ECCO 2 R reduced the circulating arterial pCO 2 and the ICP fell despite a reduction in tidal volume to 5 mL/kg predicted body weight. The reduction in plateau pressure allowed for an increase in PEEP, which led to improvement in oxygenation in combination with the effect of ECCO 2 R. Pulmonary arterial hypertension and right ventricular dysfunction gradually resolved with an improvement in left ventricular filling and reduction in pressor/inotrope requirements. This in turn led to resolution of functional LVOT obstruction on repeat TOE.
In both of these cases, breaking a vicious circle of physiological deterioration allowed the restoration of homeostasis. The second patient suffered a device-related complication (femoral arteriovenous fistula) but both patients were ultimately discharged from the ICU.
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